Barbara Duncan
Chairman bij FUSN PHAR
Vermogen: 376 412 $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Lloyd Klickstein | M | 67 |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The private company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | 3 jaar |
Andrea Corcoran | F | 61 | 11 jaar | |
Jean-Pierre Sommadossi | M | 68 | 12 jaar | |
Connie Matsui | F | 70 | 18 jaar | |
Mark Dipaolo | M | 53 | 6 jaar | |
Michael LaBarre | M | 60 | 16 jaar | |
John Valliant | M | 54 | 10 jaar | |
Odysseas Kostas | M | 49 | 7 jaar | |
Rocco Venezia | M | 48 | 8 jaar | |
Jeremy Levin | M | 70 | 10 jaar | |
Mark Snyder | M | 57 | 2 jaar | |
Nicole LaBrosse | F | 41 | 9 jaar | |
Helen Torley | M | 61 | 10 jaar | |
Jeffrey Henderson | M | 59 | 9 jaar | |
Andrew Dickinson | M | 54 | 4 jaar | |
Megan Alexander | F | - | - | |
Thomas Perone | M | 59 | 5 jaar | |
Bernadette Connaughton | F | 65 | 6 jaar | |
Jacquelyn Sandell | F | - | 5 jaar | |
Akiko Miyashita | F | 68 | 2 jaar | |
Suzanne K. Wakamoto | F | - | 9 jaar | |
Pablo Cagnoni | M | 60 | 5 jaar | |
Kevin Fitzgerald | M | 56 | 3 jaar | |
Joanne Schindler | M | - | - | |
Jason Tardio | M | 47 | 5 jaar | |
Polly Murphy | M | 59 | 4 jaar | |
Donald Bergstrom | M | 52 | 3 jaar | |
Christina Carlson | F | - | 4 jaar | |
Philina Lee | M | 47 | 3 jaar | |
Jerome Adams | M | 49 | 3 jaar | |
Eric Laub | M | - | 3 jaar | |
Maria Horga | M | 55 | 4 jaar | |
Wayne Foster | M | 55 | 5 jaar | |
Steven Gannon | M | 62 | 4 jaar | |
Mark Pruzanski | M | 56 |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The private company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | 3 jaar |
Jeffrey Rona | M | 55 | 5 jaar | |
Tram Bui | F | - | 2 jaar | |
Jules Haimovitz | M | 73 | 6 jaar | |
Jonae R. Barnes | F | - | 3 jaar | |
Bruno Lucidi | M | 64 | 10 jaar | |
Robert Poole | M | 67 | 3 jaar | |
Dirk Haasner | M | 59 | 8 jaar | |
Bart Friedman | M | 79 | 9 jaar | |
Karen Bernstein | M | 71 | 9 jaar | |
Sarah Schlesinger | M | 64 | 6 jaar | |
Franklin Berger | M | 74 | 5 jaar | |
John Furey | M | 59 | 6 jaar | |
Bruce Polsky | M | 70 | 10 jaar | |
Brett Pletcher | M | 56 | 4 jaar | |
Amanda Cray | F | - | - | |
Matthew Posard | M | 56 | 11 jaar | |
Dmitri Bobilev | M | - | 2 jaar | |
Manoj Malhotra | M | - | 1 jaar | |
Toshiya Nishi | M | - | 1 jaar | |
Todd F. Baumgartner | M | - | 3 jaar | |
Mark Fishman | M | 72 |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The private company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | - |
John Lunger | M | 55 | 7 jaar | |
Juli P. Miller | M | - | 8 jaar | |
Julia Tsai | M | - | 3 jaar | |
Garry Menzel | M | 59 | 1 jaar | |
Simon D. Kelner | M | 51 | 2 jaar | |
Zhong Zhong | M | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Matthew During | M | 67 | 5 jaar | |
Michael W. Aguiar | M | 57 | 13 jaar | |
Kimberlee Drapkin | F | 55 | 10 jaar | |
Brian Piper | M | 52 | 5 jaar | |
Arnold Lippa | M | 77 |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | 11 jaar |
Cary Pfeffer | M | 61 | 8 jaar | |
Michael R. Garone | M | 66 | 4 jaar | |
George Bickerstaff | M | 68 | 6 jaar | |
Lorenzo M. Tallarigo | M | 74 | 6 jaar | |
Jigar Raythatha | M | 47 | 8 jaar | |
James Noble | M | 65 | 15 jaar | |
Perry Karsen | M | 69 | 7 jaar | |
Richard Murray | M | 65 | 9 jaar | |
Mark Vignola | M | 46 |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | 6 jaar |
Michael Cola | M | 64 | 7 jaar | |
Timothy G. Daly | M | 52 | 6 jaar | |
Michael White | M | 72 | 19 jaar | |
Harout Semerjian | M | 52 | - | |
Richard Goodman | M | 75 | 19 jaar | |
Robert Iannone | M | 57 | 5 jaar | |
Anna L. Barry | M | - | 5 jaar | |
Charles Baum | M | 65 | 1 jaar | |
Lynn Wick | F | - | 4 jaar | |
Bryan Yoon | M | 47 | 4 jaar | |
Srini Akkaraju Akkaraju | M | 56 | 11 jaar | |
John Leaman | M | 51 | 3 jaar | |
Rafaèle Elisabeth Tordjman | M | 54 | 8 jaar | |
Robert Kamen | M | 79 | 10 jaar | |
John Duncan Higgons | M | 69 | 7 jaar | |
Chau Khuong | M | 48 | 4 jaar | |
Alastair Clemow | M | 72 | 10 jaar | |
Daniel Welch | M | 66 | 6 jaar | |
James Healy | M | 58 | 8 jaar | |
Bill Gantz | M | 86 | 5 jaar | |
Isaac Blech | M | 73 | 6 jaar | |
Scott Canute | M | 63 | 3 jaar | |
Klaus Veitinger | M | 62 | 4 jaar | |
Mallory Morales | F | 40 | 2 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 83 | 83.00% |
Canada | 10 | 10.00% |
Verenigd Koninkrijk | 6 | 6.00% |
Zwitserland | 2 | 2.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Barbara Duncan
- Persoonlijk netwerk